Green tea: prevention and treatment of cancer by nutraceuticals.
Béliveau
Richard
R
Laboratoire de Médecine Moléculaire, Hôpital Ste-Justine-UQAM, Centre de Cancérologie Charles-Bruneau, Montréal, Quebec, Canada H3T 1C. beliveau.richard@uqam.ca
Gingras
Denis
D
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015448:Leukemia, B-Cell / Q000188:drug therapy*; D009369:Neoplasms / Q000517:prevention & control*; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors*; D013662:Tea / Q000737:chemistry*
D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts; D013662:Tea; D002392:Catechin; C045651:epigallocatechin gallate; D040262:Receptors, Vascular Endothelial Growth Factor